ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma in Cirrhotic Livers.

    M. Samoylova, N. Mehta, J. Roberts, F. Yao.

    University of California, San Francisco, San Francisco, CA.

    Background: Current guidelines recommend ultrasound (US) for hepatocellular carcinoma (HCC) surveillance in cirrhotic livers. However, certain patient and disease characteristics may pose a technical challenge…
  • 2016 American Transplant Congress

    Long-Term Assessment of the Safety and Efficacy of IVIG and Rituximab-Based Desensitization (DES).

    J. Choi, J. Kahwaji, A. Vo, S. Louie, A. Kang, A. Peng, R. Villicana, D. Puliyanda, I. Kim, S. Jordan.

    Comprehensive Transplantation Center, Cedars-Sinai Medical Center, Los Angeles, CA.

    Introduction: HLA sensitized patients constitute a growing number of ESRD patients with an immunologic barrier to successful transplantation. Desensitization (DES) therapies have emerged to address…
  • 2016 American Transplant Congress

    Muscle Function, Mass, and Quality in Obese Liver Transplant Candidates: Results from the Functional Assessment in Liver Transplantation (FrAILT) Study.

    C. Wang, I. Lobach, J. Lai.

    UCSF, San Francisco, CA.

    Background: Sarcopenia, or severe loss of muscle mass, is common in cirrhotics and adversely affects quality of life and transplant outcomes. Obese liver transplant(LT) candidates…
  • 2016 American Transplant Congress

    Engineering a “Hybrid Thymus” to Promote Transplant Tolerance.

    S. AlFadil,1 M.-J. Kim,2 M. Iglesias Lozano,1 B. Oh,1 W. Lee,1 G. Brandacher,1 T. Serworld,2 G. Raimondi.1

    1Plastic & Recnstructive Surgery, Johns Hopkins Medical Institute, Baltimore, MD; 2Joslin Diabetes Center, Boston, MA.

    Purpose: Targeting the process of central (thymic) selection of developing T lymphocytes is the key tolerogenic mechanism of bone marrow transplantation (BM-Tx)-based protocols for transplant…
  • 2016 American Transplant Congress

    CMV Immune Monitoring with a CMV ELISPOT Test in Kidney Transplant Patients.

    S. Ball, A. Small, C. Waite.

    Department of Renal Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.

    Cytomegalovirus (CMV) is an important opportunistic infection in kidney transplant recipients (KTR). Whilst pre-emptive or prophylactic anti-viral regime reduce CMV complications, drug toxicity and resistance…
  • 2016 American Transplant Congress

    Conditional Deletion of mTOR in Myeloid Cells Inhibits Chronic Allograft Rejection – A Novel Role for Macrophages in Transplant Vasculopathy.

    Y. Zhao, W. Chen, P. Lan, X. Xiao, W. Liu, M. Kloc, Y. Liu, R. Ghobrial, O. Gaber, X. Li.

    Immunobiology & Transplant Research Center, Houston Methodist Hospital and Houston Methodist Research Institute, Houston, TX.

    Most transplants eventually lost to chronic rejection under potent immunosuppression therapies where activation of innate immunity is suspected to play a major role in graft…
  • 2016 American Transplant Congress

    Impact of Early Hospital Readmission Following Simultaneous Pancreas Kidney Transplantation.

    E. King, L. Kucirka, M. McAdams-DeMarco, M. Bowring, A. Massie, D. Segev.

    Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD.

    BACKGROUND: Our group recently demonstrated that 54% of simultaneous pancreas kidney (SPK) recipients experience early hospital readmission (EHR). It is unknown whether EHR following SPK…
  • 2016 American Transplant Congress

    Metallothionein Accelerates Anti-MHC Induced Small Airway Obliteration and Fibrosis by Negatively Regulating IL-10 and Regulatory Cells.

    D. Nayak,1,2 F. Zhou,1 N. Benshoff,1 T. Mohanakumar.1,2

    1Washington Univ Sch Med, St. Louis, MO; 2Norton Thoracic Institute, St. Joseph Hospital, Phoenix, AZ.

    Development of bronchiolitis obliterans syndrome (BOS), chronic lung allograft rejection, is a major obstacle to long-term success from lung transplantation. De novo antibodies (Abs) to…
  • 2016 American Transplant Congress

    mTORC2 Negatively Regulates Dendritic Cell (DC) Metabolism and the Allostimulatory Function of Donor DCs in Organ Transplantation.

    A. Watson,1,2 D. Raïche-Regué,1 H. Dai,1 K. Fabian,3,4 G. Delgoffe,4,5 W. Storkus,3,4 A. Thomson.1,2

    1Starzl Transplantation Institute, Univ. of Pittsburgh, Pittsburgh, PA; 2Pathology, Univ. of Pittsburgh, Pittsburgh, PA; 3Dermatology, Univ. of Pittsburgh, Pittsburgh, PA; 4Immunology, Univ. of Pittsburgh, Pittsburgh, PA; 5Cancer Institute, Univ. of Pittsburgh, Pittsburgh, PA.

    The mechanistic target of rapamycin (mTOR) is a kinase that functions in at least two complexes: rapamycin (RAPA)-sensitive mTORC1 and RAPA-insensitive mTORC2. These complexes play…
  • 2016 American Transplant Congress

    Relationship Between Clinical Events and Everolimus Exposure at 12 Months in De Novo Renal Transplant Recipients.

    F. Shihab,1 Y. Qazi,2 S. Mulgaonkar,3 K. McCague,4 D. Patel,4 V. Peddi,5 D. Shaffer.6

    1University of Utah, Salt Lake City, UT; 2University of Southern California, Los Angeles, CA; 3Barnabas Health, West Orange, NJ; 4Novartis Pharmaceuticals Corporation, East Hannover, NJ; 5California Pacific Medical Center, San Francisco, CA; 6Vanderbilt University, Nashville, TN.

    We assessed the incidence of post-transplant biopsy-proven acute rejection (BPAR), graft loss and other adverse events (AEs) associated with everolimus (EVR) and tacrolimus (TAC) exposure…
  • « Previous Page
  • 1
  • …
  • 165
  • 166
  • 167
  • 168
  • 169
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences